Ad hoc according to Art. 17 paragraph 1 MAR LANXESS signs contract to sell Urethane Systems business for an enterprise value of €460 m to UBE Corporation - proceeds will be used to reduce net financial debt   Specialty chemicals company LANXESS signed a contract to sell its Urethane Systems business to UBE Corporation on 3rd October, [ … ]

          Ad hoc according to Art. 17 paragraph 1 MAR LANXESS: EBITDA pre exceptionals for second quarter 2024 significantly above market expectation Specialty chemicals company LANXESS expects to achieve a second quarter 2024 EBITDA pre exceptionals that considerably exceeds average market expectation and previous year's level. The preliminary [ … ]

           Ad hoc according to Art. 17 paragraph 1 MAR Impairment of goodwill and adjustment of at-equity book value of minority interest in Envalior During the preparation of annual financial statements for the year 2023, LANXESS identified an impairment requirement on goodwill amounting to EUR 413 million. The impairment incurred in the Busine [ … ]